-1.19 | -3.30%
-6.59%
| GROWTH | 12 Mo | 3 Yr | CAGR |
| Revenue | -22.40 | -0.06 | -0.02 |
| Net Income | -34.50 | -0.16 | -0.06 |
| EPS | -32.00 | -0.15 | -0.05 |
| GSK | Sector Avg. | S&P 500 |
| 9.01 | 13.80 | 36.70 |
| Price Chng | 3 Mo | 1 Yr | 3 Yr |
| 10.77 | -22.86 | -37.61 |
| EBITDA | 11.26B |
| REVENUE | 35.01B |